Production (Stage)
Burning Rock Biotech Limited
BNR
$3.56
$0.17415.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 89.04% | 49.70% | 79.33% | 37.47% | 37.47% |
| Total Depreciation and Amortization | -- | -60.76% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -58.12% | -- | -- | -- |
| Total Other Non-Cash Items | -112.17% | 30.87% | -95.66% | 7.50% | 7.50% |
| Change in Net Operating Assets | -- | 29.70% | -- | -- | -- |
| Cash from Operations | 42.25% | 219.44% | 35.39% | 66.13% | 66.13% |
| Capital Expenditure | -- | 32.88% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 1,775.86% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.65% | -60.30% | 49.69% | 43.99% | 43.99% |
| Cash from Investing | 36.65% | -148.68% | 49.69% | 43.99% | 43.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 98.97% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.04% | 100.00% | -- | -- |
| Cash from Financing | -- | 96.10% | 100.00% | -- | -- |
| Foreign Exchange rate Adjustments | 460.81% | 275.77% | -188.78% | 101.03% | 101.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 42.56% | 211.48% | 63.53% | 66.80% | 66.80% |